ACOSTA, MELISSA, W.   NORTON ROSE FULBRIGHT
72
Patents represented
Technical areasPatents
Biotechnology29
Medical technology10
Food chemistry7
Computer technology5
Pharmaceuticals4

Countries of applicants

Summary

ACOSTA, Melissa, W. is very experienced in the technologies „Biotechnology“ and „Medical technology“. 58% of all patents are related to „(Bio)Chemistry“. Most important clients are „BAYLOR COLLEGE OF MEDICINE“ and „AGENNIX INCORPORATED“. ACOSTA, Melissa, W. was very active in 2003 and 2004. Oftentimes, clients are from United States.

Patents by year

Patents by area

5
Patent applications
11
Patent applications
42
Patent applications
6
Patent applications

Patents by applicant

RankNameCountryPatents
1BAYLOR COLLEGE OF MEDICINEUnited States20
2AGENNIX INCORPORATEDUnited States12
3MARS, INCORPORATEDUnited States9
4ADVANCED NEUROMODULATION SYSTEMS, INC.Canada8
5BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMUnited States7
6UNIVERSITY OF MARYLAND, BALTIMOREUnited States3
7WYETHChina3
8BAYLOR COLLEGE OF MEDECINEUnited States2
9DEPARTMENT OF VETERANS AFFAIRSUnited States2
10THE TEXAS A & M UNIVERSITY SYSTEMUnited States2
11BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEMUnited States1
12BOND, RICHARD, A.United States1
13DODDS, W., JEANUnited States1
14HANKS, BRENTUnited States1
15HEMOPETUnited States1
16IONWERKS, INC.United States1
17MARS, INC.United States1
18PEDIAMED PHARMACEUTICALS, INC.United States1
19PROTEIN THERAPEUTICS, INC.United States1
20RESEARCH DEVELOPMENT FOUNDATIONUnited States1
21SLAWIN, KEVINUnited States1
22SPENCER, DAVIDUnited States1
23THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICESUnited States1

Latest patents

Publication numberTitlePatent applicantYear
WO2009148692SYSTEMS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERS (ASD) AND RELATED DYSFUNCTIONSADVANCED NEUROMODULATION SYSTEMS, INC.
2009
WO2009073891SYSTEMS AND METHODS FOR PROVIDING TARGETED NEURAL STIMULATION THERAPY TO ADDRESS NEUROLOGICAL DISORDERS, INCLUDING NEUROPYSCHIATRIC AND NEUROPYSCHOLOGICAL DISORDERSADVANCED NEUROMODULATION SYSTEMS, INC.
2009
WO2008157182METHOD FOR SELECTING ELECTRODES FOR DEEP BRIAN OR CORTICAL STIMULATION AND PULSE GENERATOR FOR DEEP BRIAN OR CORTICAL STIMULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2008
WO2007050565INCORPORATION OF ANTIMICROBIAL COMBINATIONS ONTO DEVICES TO REDUCE INFECTIONTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH AND HUMAN SERVICES
BAYLOR COLLEGE OF MEDICINE
2007
WO2006138324TREPONEMA PALLIDUM ANTIGENS FOR VACCINE DEVELOPMENT AND DIAGNOSTIC TESTSBAYLOR COLLEGE OF MEDICINE
2006
WO2006047744COMPOSITIONS OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOFAGENNIX INCORPORATED
2006
WO2006044523BIOMARKERS FOR USE IN VESSEL DISORDERSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
2006
WO2006036213THE USE OF GAMMAGLOBULIN FOR THE TREATMENT OF PERIODONTAL DISEASEPEDIAMED PHARMACEUTICALS, INC.
2006
WO2006036278THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOFDEPARTMENT OF VETERANS AFFAIRS
UNIVERSITY OF MARYLAND, BALTIMORE
2006
WO2006034048THERAPEUTIC AGENTS TARGETING THE NCCA-ATP CHANNEL AND METHODS OF USE THEREOFUNIVERSITY OF MARYLAND, BALTIMORE
DEPARTMENT OF VETERANS AFFAIRS
2006
WO2006014896STIMULATION SYSTEM AND METHOD TREATING A NEUROLOGICAL DISORDERADVANCED NEUROMODULATION SYSTEMS, INC.
2006
WO2005113069USE OF CIRCUMIN AND ANALOGUES AS INHIBITORS OF ACC2RESEARCH DEVELOPMENT FOUNDATION
2005
WO2005107858METHOD OF TREATING MOOD DISORDERS AND/OR ANXIETY DISORDERS BY BRAIN STIMULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005087314BRAIN STIMULATION SYSTEM AND METHODADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005051480ELECTRICAL STIMULATION SYSTEM, LEAD, AND METHOD PROVIDING REDUCED NEUROPLASTICITY EFFECTSADVANCED NEUROMODULATION SYSTEMS, INC.
2005
WO2005046571LACTOFERRIN AS AN ADJUVANT IN CANCER VACCINESAGENNIX INCORPORATED
2005
WO2005032452ALKYL-SUBSTITUTED PCDF AS A TREATMENT FOR PROSTATE CANCERTHE TEXAS A & M UNIVERSITY SYSTEM
2005
WO2005027902MODULATORS OF Cdk9 AS A THERAPEUTIC TARGET IN CARDIAC HYPERTROPHYBAYLOR COLLEGE OF MEDICINE
2005
WO2005018542USE OF LACTOFERRIN IN PROPHYLAXIS AGAINST INFECTION AND/OR INFLAMMATION IN IMMUNOSUPPRESSED SUBJECTSAGENNIX INCORPORATED
2005
WO2004112894METHOD OF TREATING DEPRESSION, MOOD DISORDERS AND ANXIETY DISORDERS USING NEUROMODULATIONADVANCED NEUROMODULATION SYSTEMS, INC.
2004
WO2004109255RAPID SCREENING OF BIOGENIC PARTICLES IN COLLECTED AEROSOLSIONWERKS, INC.
2004
WO2004103285LACTOFERRIN IN THE TREATMENT OF DIABETES MELLITUSAGENNIX INCORPORATED
2004
WO2004094610WNT AS A FACTOR FOR CARDIAC MYOGENESISBAYLOR COLLEGE OF MEDICINE
2004
WO2004092395MODULATORS OF TELOMERE STABILITYBAYLOR COLLEGE OF MEDICINE
2004
WO2004073641INDUCED ACTIVATION IN DENDRITIC CELLSHANKS, BRENT
SLAWIN, KEVIN
SPENCER, DAVID
2004